Elevated hematocrit, the percentage of red blood cells in the blood, can occur during testosterone replacement therapy (TRT). Managing this elevation is important for cardiovascular health and overall well-being. Potential strategies focus on reducing red blood cell mass or increasing plasma volume. Examples include blood donation (phlebotomy), adjusting TRT dosage, and ensuring adequate hydration.
Maintaining a healthy hematocrit level is crucial while undergoing TRT, as consistently high levels can increase the risk of blood clots and cardiovascular complications. Understanding the potential consequences of unchecked hematocrit, and proactively managing it, contributes to maximizing the benefits and minimizing the risks associated with TRT. Historically, observation of increased blood viscosity led to the recognition of the importance of monitoring and managing hematocrit during androgen therapy.